Overcoming the Difficulties in ADC Drug Substance Development with an Integrated Platform

  • Addressing ADC’s multi-component unique chemistries and handling needs, which must be precisely contained and integrated for ADCs to function 
  • Preserving quality and consistency while moving from lab-scale ADC synthesis to clinical and commercial scale, managed across several outsourcing partners
  • Achieving the best possible stability in circulation while guaranteeing effective payload release at the destination
  • Advanced analytical techniques are required for ADCs for stability, impurity profiling, DAR distribution, and characterisation